| 产品编号 | CFN91038 | |
| CAS编号 | 1343403-10-0 | |
| 分子式 = 分子量 | C15H20O4 = 264.3 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Sesquiterpenoids | |
| 植物来源 | The roots of Inula helenium L. | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 1mg | QQ客服:3257982914 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 5mg | QQ客服:3257982914 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 10mg | QQ客服:3257982914 |
| 环氧土木香内酯 | CFN91038 | 1343403-10-0 | 20mg | QQ客服:3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Epoxymicheliolide, a novelguaiane-type sesquiterpene lactone, inhibits NF‑κB/COX‑2 signaling pathways by targeting leucine 281 and leucine 25 in IKKβ in renal cell carcinoma, it may be a novel anticancer agent in the treatment of renal cell carcinoma. |
| Targets: | NF‑κB | COX‑2 |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.7836 mL | 18.9179 mL | 37.8358 mL | 75.6716 mL | 94.5895 mL |
| 5 mM | 0.7567 mL | 3.7836 mL | 7.5672 mL | 15.1343 mL | 18.9179 mL |
| 10 mM | 0.3784 mL | 1.8918 mL | 3.7836 mL | 7.5672 mL | 9.4589 mL |
| 50 mM | 0.0757 mL | 0.3784 mL | 0.7567 mL | 1.5134 mL | 1.8918 mL |
| 100 mM | 0.0378 mL | 0.1892 mL | 0.3784 mL | 0.7567 mL | 0.9459 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 甲基麦冬黄酮A; Methylophiopogonone A | CFN90708 | 74805-90-6 | C19H16O6 = 340.33 | 10 mg | QQ客服:2056216494 |
| 5,7-二羟基色原酮; 5,7-Dihydroxychromone | CFN97761 | 31721-94-5 | C9H6O4 = 178.14 | 20mg | QQ客服:1413575084 |
| 多马莫德; Doramapimod (BIRB 796) | CFN60141 | 285983-48-4 | C31H37N5O3 = 527.66 | 5mg | QQ客服:3257982914 |
| 新化合物33; New compound 33 | CFN95706 | N/A | C18H20O8 = 364.4 | 5mg | QQ客服:215959384 |